Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization
- PMID: 30497863
- DOI: 10.1016/j.jvs.2018.08.169
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization
Abstract
Objective: Accurate survival prediction critically influences decision-making in caring for patients with chronic limb-threatening ischemia (CLTI). The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial demonstrated that in patients who survived >2 years, there was a significant advantage to infrainguinal bypass compared with endovascular intervention, which increased with time. Validated survival models for patients with CLTI are lacking.
Methods: The Vascular Quality Initiative was interrogated for patients who underwent infrainguinal bypass or endovascular intervention for CLTI (January 2003-February 2017). Cox survival models were generated using only preoperative variables. Survival at 30 days, 2 years, and 5 years was modeled separately. Patients were defined as low risk (30-day survival >97% and 2-year survival >70%), medium risk (30-day survival 95%-97% or 2-year survival 50%-70%), and high-risk (30-day survival <95% or 2-year survival <50%).
Results: Among 38,470 unique CLTI patients, 63% (n = 24,214) underwent endovascular intervention and 37% (n = 14,256) underwent infrainguinal bypass. Kaplan-Meier estimates of overall survival at 30 days, 2 years, and 5 years were 98%, 81%, and 69%, respectively. The proportion of patients in the low-, medium-, and high-risk groups was 84%, 10%, and 6.5%, respectively. Patients in the low-risk group were significantly less likely to undergo endovascular intervention compared with those in the high-risk group (low risk, 59% endovascular; high risk, 75% endovascular; P < .0001). Independent predictors of death were similar in all three models, with greatest magnitude of effect associated with age >80 years, oxygen-dependent chronic obstructive pulmonary disease, stage 5 chronic kidney disease, and bedbound status. The C index for the 30-day model, 2-year model, and 5-year model was 0.76, 0.72, and 0.71, respectively. Procedure type (open or endovascular) was not significant in any models and did not have an impact on C indices.
Conclusions: These survival prediction models, derived from a large U.S. cohort of patients who underwent revascularization for CLTI, demonstrated good performance and should be validated. Most CLTI patients considered candidates for limb salvage were of average perioperative risk and were predicted to survive beyond 2 years. These models can differentiate patients into low-, medium-, and high-risk groups to facilitate evidence-based revascularization recommendations that are consistent with current treatment guidelines.
Keywords: Chronic limb-threatening ischemia; Survival; Vascular Quality Initiative.
Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The Global Limb Anatomic Staging System is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia.J Vasc Surg. 2021 Jun;73(6):2009-2020.e4. doi: 10.1016/j.jvs.2020.12.094. Epub 2021 Feb 4. J Vasc Surg. 2021. PMID: 33548444
-
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.J Vasc Surg. 2019 Jun;69(6S):126S-136S. doi: 10.1016/j.jvs.2018.01.071. Epub 2019 May 28. J Vasc Surg. 2019. PMID: 31159976
-
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S120-S134.e3. doi: 10.1016/j.ejvs.2019.04.009. Epub 2019 May 28. Eur J Vasc Endovasc Surg. 2019. PMID: 31151867
-
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.J Vasc Surg. 2018 Aug;68(2):624-633. doi: 10.1016/j.jvs.2018.01.066. Epub 2018 May 24. J Vasc Surg. 2018. PMID: 29804736 Review.
-
Bypass surgery versus endovascular interventions in severe or critical limb ischemia.J Vasc Surg. 2016 Jan;63(1):244-53.e11. doi: 10.1016/j.jvs.2015.07.068. Epub 2015 Sep 11. J Vasc Surg. 2016. PMID: 26372187 Review.
Cited by
-
Machine Learning to Predict Outcomes of Endovascular Intervention for Patients With PAD.JAMA Netw Open. 2024 Mar 4;7(3):e242350. doi: 10.1001/jamanetworkopen.2024.2350. JAMA Netw Open. 2024. PMID: 38483388 Free PMC article.
-
Evaluation of endovascular treatment of chronic limb-threatening ischemia for patients in the PLAN gray zone.J Int Med Res. 2023 Nov;51(11):3000605231211768. doi: 10.1177/03000605231211768. J Int Med Res. 2023. PMID: 38000011 Free PMC article.
-
Dynamic Perfusion Computed Tomography for the Assessment of Concomitant Coronary Artery Disease in Patients with a History of Percutaneous Transluminal Angioplasty for Chronic Limb-Threatening Ischemia-A Pilot Study.J Cardiovasc Dev Dis. 2023 Oct 25;10(11):443. doi: 10.3390/jcdd10110443. J Cardiovasc Dev Dis. 2023. PMID: 37998501 Free PMC article.
-
Prognostic Value of Hospital Frailty Risk Score and Clinical Outcomes in Patients Undergoing Revascularization for Critical Limb-Threatening Ischemia.J Am Heart Assoc. 2023 Sep 5;12(17):e030294. doi: 10.1161/JAHA.123.030294. Epub 2023 Aug 29. J Am Heart Assoc. 2023. PMID: 37642031 Free PMC article.
-
Case planning and execution of inframalleolar bypass for chronic limb-threatening ischemia.J Vasc Surg Cases Innov Tech. 2023 Mar 23;9(2):101116. doi: 10.1016/j.jvscit.2023.101116. eCollection 2023 Jun. J Vasc Surg Cases Innov Tech. 2023. PMID: 37152915 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical